Drug
Who makes cangrelor?
2 companies list cangrelor as a human prescription drug, including under the names KENGREAL. Forms: injection, powder, lyophilized, for solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing cangrelor
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| GLAND PHARMA LIMITEDIndia | injection, powder, lyophilized, for solution | ANDAANDA213551 | 1 | 4 |
| Chiesi USA, Inc.Italy | injection, powder, lyophilized, for solution | NDANDA204958 | 1 | 1 |
Bulk ingredient listings
- LSNE, Inc. · 1 NDC
- Veranova, L.P.United States · 1 NDC
Orange Book patents
7 unexpired patents list cangrelor as the active ingredient, expiring between May 2029 and Jul 2035. Application holder: CHIESI USA INC.
Enquiry
Common questions
- Who makes cangrelor?
- 2 companies list cangrelor as a human prescription drug in the openFDA NDC Directory, led by GLAND PHARMA LIMITED, Chiesi USA, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic KENGREAL?
- 1 company lists cangrelor under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
- Who supplies cangrelor active ingredient?
- 2 companies list cangrelor as a bulk ingredient, including LSNE, Inc., Veranova, L.P..